Tratamiento del virus de la hepatitis B: ¿qué pacientes deben recibir tratamiento inmediato?
Robert P. Perrillo – 13 January 2014 – Watch a video presentation of this article
Robert P. Perrillo – 13 January 2014 – Watch a video presentation of this article
Andres F. Carrion,, y Paul Martin, – 13 January 2014 – Watch a video presentation of this article
Federico Piñero, Ariel Gonzalez Campaña, Manuel Mendizabal, Martín Fauda, Carlos Rowe, Pía Raffa, Mariano Barreiro, Daniel Mahuad, Pablo Testa, Diego Arufe, Oscar Andriani, Marcelo Silva, Luis G. Podestá – 13 January 2014
Kymberly D . Watt – 13 January 2014 – Watch a video presentation of this article
Kymberly D . Watt – 13 January 2014 – Watch a video presentation of this article
Julia Wattacheril,, y Naga Chalasani, – 13 January 2014 – Watch a video presentation of this article
Robert S. Rahimi, Adam C. Yopp, y Amit G. Singal – 13 January 2014 – Watch a video presentation of this article
Karolina Rembeck, Jesper Waldenström, Kristoffer Hellstrand, Staffan Nilsson, Kristina Nyström, Anna Martner, Magnus Lindh, Gunnar Norkrans, Johan Westin, Court Pedersen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Kristine Mørch, Peer Brehm Christensen, Martin Lagging – 13 January 2014 – The present study evaluated the impact of variations in the inosine triphosphate pyrophosphatase (ITPase) gene (ITPA) on treatment outcome in patients with hepatitis C virus (HCV) genotype 2/3 infection receiving peginterferon‐α2a and lower, conventional 800 mg daily dose of ribavirin.
Thomas D. Boyer, y Bruce Kaplan – 13 January 2014 – Watch a video presentation of this article
Harjit K. Bhogal,, Arun J. Sanyal, – 13 January 2014 – Watch a video presentation of this article